Osaic Holdings’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.6K Buy
3,692
+66
+2% +$633 ﹤0.01% 5588
2025
Q4
$42.2K Sell
3,626
-502
-12% -$4.88K ﹤0.01% 5354
2025
Q3
$42.8K Sell
4,128
-1,087
-21% -$15.6K ﹤0.01% 5412
2025
Q2
$91K Buy
5,215
+1,803
+53% +$26K ﹤0.01% 4589
2025
Q1
$42.9K Sell
3,412
-8,936
-72% -$108K ﹤0.01% 4836
2024
Q4
$130K Buy
12,348
+9,896
+404% +$139K ﹤0.01% 3984
2024
Q3
$35.6K Buy
2,452
+2,344
+2,170% +$27.9K ﹤0.01% 4985
2024
Q2
$918 Sell
108
-656
-86% -$5.82K ﹤0.01% 6839
2024
Q1
$7.81K Buy
764
+91
+14% +$678 ﹤0.01% 5888
2023
Q4
$3.69K Buy
+673
New +$2.95K ﹤0.01% 6288
2023
Q1
Sell
-2,000
Closed -$17K 7568
2022
Q4
$17K Hold
2,000
﹤0.01% 5682
2022
Q3
$11K Buy
+2,000
New +$9.86K ﹤0.01% 5979

Other funds holding SPRY